Jerusalem Pharmaceuticals Company reported audited consolidated earnings results for the year 2013. For the year, the company reported net profit after taxes reached USD 2,248,123 compared with a net profit after taxes of USD 195,591 for 2012, a net increase of 1,049.4%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | -0.82% |
|
-0.82% | -4.74% |
1st Jan change | Capi. | |
---|---|---|
-4.74% | 6.52Cr | |
+20.76% | 4.36TCr | |
+28.00% | 2.25TCr | |
+20.25% | 1.57TCr | |
+18.82% | 1.43TCr | |
+55.83% | 1.27TCr | |
-0.05% | 678.76Cr | |
-12.70% | 647.97Cr | |
-8.87% | 572.55Cr | |
+14.65% | 567.13Cr |
- Stock Market
- Equities
- JPH Stock
- News Jerusalem Pharmaceuticals Co. Ltd.
- Jerusalem Pharmaceuticals Company Reports Audited Consolidated Earnings Results for the Year 2013